HEALTH

LOS ANGELES — Clif Bar on Tuesday boosted its commitment to the Honda LA Marathon with a two-year sponsorship for 2012 and 2013. Clif Bar will provide Honda LA Marathon runners with an array of sports nutrition made with organic ingredients, including Clif Bar energy bars, Clif Shot energy gel and Clif Shot Bloks energy chews.

NEW YORK — Record-breaking attendance, a high-profile keynote speaker, four engaging panel discussions on some of the hottest issues facing the industry and exclusive consumer videos set the stage for the 13th annual Drug Store News Industry Issues Summit held on Tuesday in New York.

GALESBURG, Ill. — Local doctor Paul Kinsinger is gaining traction for his Dr. Paul's Piggy Paste product, a cream to improve toenail appearance, according to an article published Monday by the Register-Mail.

FERNDALE, Wash. — Botanical Labs on Monday launched a bariatric-focused line of liquid dietary supplements called Wellesse Bariatric Liquid Solutions.

According to the company, bariatric surgical treatment is one of the faster growing options to assist with weight loss. Weight-loss surgery patients have special pre- and post-surgery nutritional requirements. Wellesse targets specific nutrient deficiencies within the weight loss surgery community with the same dedication offered to existing consumers.

NEW YORK — The short-term forecast for cold weather items, including cold medicines, is that demand could be down as much as 15% without Jack Frost biting at everyone’s nose, according to analysis from Deutsche Bank published Monday.

Weather Trends International estimates temperatures will be up 2 to 5 degrees warmer year-over-year, on average, over the balance of the year across the United States.

KANSAS CITY, Kan. — A study published online earlier this month by the American Journal of Cardiology concluded that supplementation with vitamin D conferred substantial survival benefits, specifically in patients with documented deficiency.

According to the research, evidence supported an association between vitamin D deficiency and hypertension, peripheral vascular disease, diabetes mellitus, metabolic syndrome, coronary artery disease and heart failure.

ATLANTA — Many elderly patients put themselves at risk for emergency hospitalization due to adverse drug events, according to a new Centers for Disease Control and Prevention study published in the New England Journal of Medicine.

OSAKA, Japan — A U.S. subsidiary of Takeda Pharmaceutical has filed for regulatory approval of a drug designed to treat Type 2 diabetes, the company said.

The Takeda Global Research and Development Center filed with the Food and Drug Administration for approval of an alogliptin-metformin combination tablet. The company expects the FDA to review the application within the next 10 months.